Bioactivity and the first transmission electron microscopy immunogold studies of short de novo-designed antimicrobial peptides

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 5, 2011, Pages 2137-2145

  Azad, Marisa Ann ^a   Huttunen Hennelly, Heidi Esther Katrina ^a   Friedman, Cynthia Ross ^a  

^a THOMPSON RIVERS UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCINE; MA D PEPTIDE; MAW 1 PEPTIDE; MAW 2 PEPTIDE; MAW 3 PEPTIDE; PEP 1 PEPTIDE; POLYCATION; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; HEMOLYSIS; HYDROPHOBICITY; IMMUNOGOLD ELECTRON MICROSCOPY; INCUBATION TIME; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY;

ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 79955537634     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01148-10     Document Type: Article

References (43)

1. Bernardo, S. M., Z. Khalique, J. Kot, J. K. Jones, and S. A. Lee. 2008. Candida albicans VPS1 contributes to protease secretion, filamentation, and biofilm formation. Fungal Genet. Biol. 45:861-877.
2. Bessalle, R., et al. 1993. Structure-function studies of amphiphilic antibacterial peptides. J. Med. Chem. 36:1203-1209.
3. Black, J. G. 1996. Microbiology: principles and applications, 3rd ed. Prentice Hall, Upper Saddle River, NJ.
4. Boman, H. 2003. Antibacterial peptides: basic facts and emerging concepts. J. Int. Med. 254:197-215.
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
6. Brogden, K. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
7. Cavanagh, J., W. J. Fairbrother, A. G. Palmer, and N. J. Skelton. 1996. Protein NMR spectroscopy: principles and practice. Academic Press, San Diego, CA.
8. Chen, Y., et al. 2005. Rational design of α-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index. J. Biol. Chem. 280:12316-12329.
9. Dennison, S. R., J. Wallace, F. Harris, and D. A. Phoenix. 2005. Amphiphilic α-helical antimicrobial peptides and their structure/function relationships. Protein Pept. Lett. 12:31-39.
10. Gibbons, S., M. Oluwatuyi, and G. W. Kaatz. 2003. A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus. J. Antimicrob. Chemother. 51:13-17.
11. Giuliani, A. et al. 2008. Antimicrobial peptides: natural templates for synthetic membrane-active compounds. Cell. Mol. Life Sci. 65:2450-2460.
12. Greenfield, N. J. 2006. Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc. 1:2876-2890.
13. Hancock, R. E. W., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
14. Handler, A. A., J. E. Lim, and R. Losick. 2008. Peptide inhibitor of cytokinesis during sporulation in Bacillus subtilis. Mol. Microbiol. 68:588-599.
15. Huang, H. W. 2006. Molecular mechanisms of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 1758:1292-1302.
16. Huang, H. W. 2009. Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys. J. 96:3263-3272.
17. Huttunen-Hennelly, H. E. K. 2010. An investigation into the N- and C-capping effects of glycine in cavitand-based four-helix bundle proteins. Bioorg. Chem. 38:98-107.
18. Huttunen-Hennelly, H. E. K., and J. C. Sherman. 2007. The design, synthesis, and characterization of the first cavitand-based de novo hetero-template-assembled synthetic proteins (hetero-TASPs). Org. Biomol. Chem. 5:3637-3650.
19. Hwang, P. M., and H. J. Vogel. 1998. Structure-function relationships of antimicrobial peptides. Biochem. Cell Biol. 76:235-246.
20. Jenssen, H., P. Hamill, and R. E. W. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 3:491-511.
21. Lippa, A. M., and M. Goulian. 2009. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet. 5:1-9.
22. Lupa-Sieprawska, M., et al. 2004. Degradation of human antimicrobial LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48:4673-4679.
23. Marqusee, S., and R. L. Baldwin. 1987. Helix stabilization by Glu-Lys+ salt bridges in short peptides of de novo design. Proc. Natl. Acad. Sci. U. S. A. 84:8898-8902.
24. Matsuzaki, K., O. Murase, N. Fujii, and K. Miyajima. 1996. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35:11361-11368. (Pubitemid 26299310)
25. Matsuzaki, K., K. Sugishita, N. Fujii, and K. Miyajima. 1996. Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry 34:3423-3429.
26. Matsuzaki, K., K. Sugishita, M. Harada, N. Fujii, and K. Miyajima. 1997. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1327:119-130.
27. Neville, F., et al. 2006. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys. J. 90:1275-1287.
28. Pace, C. N., and J. M. Scholtz. 1998. A helix propensity based on experimental studies of peptides and proteins. Biophys. J. 75:422-427.
29. Podorieszach, A. P., and H. E. K. Huttunen-Hennelly. 2010. The effects of tryptophan and hydrophobicity on the structure and bioactivity of novel indolicidin derivatives with promising pharmaceutical potential. Org. Biomol. Chem. 8:1679-1687.
30. Powers, J., and R. E. W. Hancock. 2003. The relationship between peptide structure and antibacterial activity. Peptides 24:1681-1691.
31. Radek, K., and R. Gallo. 2007. Antimicrobial peptides: natural effectors of the innate immune system. Semin. Immunopathol. 29:27-43.
32. Ramamoorthy, A., D. Lee, T. Narasimhaswamy, and R. P. R. Nanga. 2010. Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. Biochim. Biophys. Acta 1798:223-227.
33. Ross Friedman, C., B. B. Ross, and G. Martens. 2009. Antibodies raised against tobacco aquaporins of the PIP2 class label the viscin tissue of the explosive dwarf mistletoe fruit. Plant Biol. 12:229-233.
34. Saxena, S., and C. Gomber. 2010. Surmounting antimicrobial resistance in the millennium superbug: Staphylococcus aureus. Cent. Eur. J. Med. 5:12-29.
35. Schibli, D. J., R. F. Epand, H. J. Vogel, and R. M. Epan. 2002. Tryptophanrich antimicrobial peptides: comparative properties and membrane interactions. Biochem. Cell Biol. 88:667-677.
36. Sengupta, D., H. Leontiadou, A. E. Mark, and S. Marrink. 2008. Toroidal pores formed by antimicrobial peptides show significant disorder. Biochim. Biophys. Acta 1778:2308-2317.
37. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta 1462:55-70.
38. Stumpe, S., R. Schmid, D. L. Stephens, G. Georgiou, and E. P. Bakker. 1998. Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells in Escherichia coli. J. Bacteriol. 180:4002-4006.
39. Wuthrich, K. 1986. NMR of proteins and nucleic acids. Wiley, New York, NY.
40. Yan, L., and M. E. Adams. 1998. Lycotoxins, antimicrobial peptides from venom of the wolf spider Lycosa carolinesis. J. Biol. Chem. 273:2059-2066.
41. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
42. Zelezetsky, I., and A. Tossi. 2006. Alpha-helical antimicrobial peptides - using a sequence template to guide structure-activity relationship studies. Biochim. Biophys. Acta 1758:1436-1449.
43. Zhu, W. L., et al. 2006. Improvement of bacterial cell selectivity of melittin by a single trp mutation with a peptoid residue. Protein Pept. Lett. 13:719-725.